ProQR Therapeutics N.V.
PRQR
$1.80
$0.042.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.85% | 25.77% | 36.52% | 29.15% | 17.67% |
| Total Receivables | 184.55% | 105.15% | -41.51% | -12.37% | 49.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 23.62% | 17.21% | 114.48% | 126.00% | 184.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -26.19% | 26.73% | 33.85% | 29.10% | 19.10% |
|
|
|||||
| Total Current Assets | -26.19% | 26.73% | 33.85% | 29.10% | 19.10% |
| Net Property, Plant & Equipment | 1.49% | -5.14% | -10.77% | -18.47% | -21.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -23.87% | 22.43% | 27.70% | 22.68% | 14.09% |
|
|
|||||
| Total Accounts Payable | 2,007.83% | 934.39% | 4,156.50% | 25.32% | -99.03% |
| Total Accrued Expenses | -- | -90.70% | -78.73% | -64.62% | -16.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.35% | 15.51% | 14.43% | 4.67% | 256.84% |
| Total Finance Division Other Current Liabilities | -6.67% | -14.67% | -7.17% | -0.43% | -0.38% |
| Total Other Current Liabilities | -6.67% | -14.67% | -7.17% | -0.43% | -0.38% |
| Total Current Liabilities | -5.43% | -12.06% | -2.72% | -1.86% | 6.53% |
|
|
|||||
| Total Current Liabilities | -5.43% | -12.06% | -2.72% | -1.86% | 6.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.17% | -8.38% | -12.16% | -19.56% | -25.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -17.56% | -17.41% | -15.11% | -31.29% | -37.59% |
| Total Liabilities | -9.47% | -13.55% | -9.23% | -18.15% | -22.93% |
|
|
|||||
| Common Stock & APIC | 13.42% | 23.32% | 28.49% | -81.01% | 9.83% |
| Retained Earnings | -24.12% | -15.44% | -19.54% | -- | 0.19% |
| Treasury Stock & Other | 17.90% | 9.25% | 7.98% | -- | -0.49% |
| Total Common Equity | -36.77% | 140.32% | 123.47% | 127.10% | 100.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.77% | 140.32% | 123.47% | 127.10% | 100.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.77% | 140.32% | 123.47% | 127.10% | 100.41% |
|
|
|||||